Skip to content
Latest
STOX.NEWS
In focus
Revenue

Moderna raises its revenue outlook — but all eyes are on what happens next with its experimental cancer vaccine

Image supplied by MarketWatch.
Advertisement
Demo creative for ADG7 Article top (728x90)

The company lifted its revenue outlook for the year, saying it expects revenue to grow as much as 25% in 2026.

Advertisement
Demo creative for ADG8 Article body (336x280)

Companies named

More on this